AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials Treatment could come with advantages, but similar therapies have seen liver issues

https://www.statnews.com/2026/06/08/astrazeneca-obesity-diabetes-treatment-studies/ By Elaine ChenJune 8, 2026 Chen, a national biotech reporter, is the co-author of The Readout, a newsletter about the business, science, and politics of biotech.